MediciNova, Inc.
MNOV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $0 | $4 |
| % Growth | -100% | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $1 | $0 | $4 |
| % Margin | – | 100% | – | 100% |
| R&D Expenses | $7 | $6 | $9 | $8 |
| G&A Expenses | $5 | $5 | $5 | $5 |
| SG&A Expenses | $5 | $5 | $5 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | $0 | $0 |
| Operating Expenses | $13 | $11 | $15 | $14 |
| Operating Income | -$13 | -$10 | -$15 | -$10 |
| % Margin | – | -990% | – | -253% |
| Other Income/Exp. Net | $2 | $1 | $1 | $0 |
| Pre-Tax Income | -$11 | -$9 | -$14 | -$10 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11 | -$9 | -$14 | -$10 |
| % Margin | – | -857.2% | – | -251% |
| EPS | -0.23 | -0.17 | -0.29 | -0.21 |
| % Growth | -35.3% | 41.4% | -38.1% | – |
| EPS Diluted | -0.23 | -0.17 | -0.29 | -0.21 |
| Weighted Avg Shares Out | 49 | 49 | 49 | 49 |
| Weighted Avg Shares Out Dil | 49 | 49 | 49 | 49 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$13 | -$10 | -$15 | -$10 |
| % Margin | – | -988% | – | -252.4% |